CIK 0000873303 · Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 930797222
- Phone
- 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Nicaise Claude Director | Sale | −2,491 | $99.64 | $248K | 27,812 |
| 2025-03-12 | Nicaise Claude Director | Option exercise · Stock Options (right to buy) | −9,746 | 0 | ||
| 2025-03-10 | Connelly Deirdre P Director | Grant or award | +2,383 | 5,225 | ||
| 2025-03-10 | Connelly Deirdre P Director | Grant or award · Stock Options (right to buy) | +4,792 | 4,792 | ||
| 2025-03-10 | Boor Kathryn Jean Director | Grant or award | +2,383 | 8,263 | ||
| 2025-03-10 | Boor Kathryn Jean Director | Grant or award · Stock Options (right to buy) | +4,792 | 4,792 | ||
| 2025-03-10 | Chambers Michael Andrew Director | Grant or award | +2,383 | 10,660 | ||
| 2025-03-10 | Chambers Michael Andrew Director | Grant or award · Stock Options (right to buy) | +4,792 | 4,792 | ||
| 2025-03-10 | Rothfuss Cristin EVP, General Counsel | Shares withheld for taxes | −491 | $100.13 | $49K | 12,834 |
| 2025-03-10 | Rothfuss Cristin EVP, General Counsel | Grant or award | +8,276 | 21,110 | ||
| 2025-03-10 | Rothfuss Cristin EVP, General Counsel | Grant or award · Stock Options (right to buy) | +16,644 | 16,644 | ||
| 2025-03-10 | Wigzell Hans Lennart Rudolf Director | Grant or award | +2,383 | 25,223 | ||
| 2025-03-10 | Wigzell Hans Lennart Rudolf Director | Grant or award · Stock Options (right to buy) | +4,792 | 4,792 | ||
| 2025-03-10 | Mayo Stephen Director | Grant or award | +2,383 | 9,004 | ||
| 2025-03-10 | Mayo Stephen Director | Grant or award · Stock Options (right to buy) | +4,792 | 4,792 | ||
| 2025-03-10 | Arif Bilal Chief Tech Ops Officer | Shares withheld for taxes | −523 | $100.13 | $52K | 24,224 |
| 2025-03-10 | Arif Bilal Chief Tech Ops Officer | Grant or award | +8,276 | 32,500 | ||
| 2025-03-10 | Arif Bilal Chief Tech Ops Officer | Grant or award · Stock Options (right to buy) | +16,644 | 16,644 | ||
| 2025-03-10 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −924 | $100.13 | $93K | 78,894 |
| 2025-03-10 | Rodino-Klapac Louise Head of R&D, CSO | Shares withheld for taxes | −2,539 | $100.13 | $254K | 76,355 |
Page 5 of 12 · 227 trades